AdaptHealth CTO Albert Prast sold 135,443 shares (42.8% of holdings) at $10.41; stock now $11.48, up 32.6% in 30 days
CTO Prast divested 135,443 shares for $1,409,961.63, reducing his stake from 316,526 to 181,083 shares—a significant 42.8% reduction in his pre-transaction holdings. The sale occurred at $10.41 on 2024-03-04, while the stock currently trades at $11.48 and has gained 32.6% over the past 30 days, suggesting the insider sold before a material near-term rally. Prast's cross-ticker track record shows 2 prior sells with a 90-day well-timed rate of 100%, and his same-ticker history at AHCO (2 prior sells on 2023-08-10) both registered negative 90-day returns of -23.9% and -27.7%, indicating consistent pattern recognition preceding price declines at the 90-day horizon. However, the current price action—32.6% appreciation in 30 days following this March sale—diverges from his established timing pattern, warranting examination of whether fundamental shifts (the company was unprofitable over its most recent full fiscal year, though latest quarter revenue is $806.0M with net income of $19.4M) or other factors altered the investment thesis.